Skip to main content
SpringerLink
Log in

Defects of Innate Immunity

  • Chapter
  • First Online:
Book cover Management of Infections in the Immunocompromised Host

  • 1004 Accesses

Abstract

White blood cells (WBCs) encompass a diversity of cells, which can be classified into two broad categories: lymphoid (T, B, NK, and NKT) and myeloid (neutrophils, eosinophils, basophils, and monocytes/macrophages, as well as those derived from the same progenitors, erythroid, and megakaryocytic). This chapter focuses primarily on neutrophils and monocytes and examines the disorders characterized by their quantitative and functional defects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Celkan T, Koc BS. Approach to the patient with neutropenia in childhood. Turk Pediatri Arsivi. 2015;50:136–44. https://doi.org/10.5152/TurkPediatriArs.2015.2295.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Dong F, et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995;333:487–93. https://doi.org/10.1056/nejm199508243330804.

    Article  PubMed  CAS  Google Scholar 

  3. Germeshausen M, Skokowa J, Ballmaier M, Zeidler C, Welte K. G-CSF receptor mutations in patients with congenital neutropenia. Curr Opin Hematol. 2008;15:332–7. https://doi.org/10.1097/MOH.0b013e328303b9f6.

    Article  PubMed  CAS  Google Scholar 

  4. Dale DC, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol. 2003;72:82–93. https://doi.org/10.1002/ajh.10255.

    Article  PubMed  Google Scholar 

  5. Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012;19:44–51. https://doi.org/10.1097/MOH.0b013e32834da96e.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kostmann R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl. 1956;45:1–78.

    Article  CAS  PubMed  Google Scholar 

  7. Klein C, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39:86–92. https://doi.org/10.1038/ng1940.

    Article  PubMed  CAS  Google Scholar 

  8. Germeshausen M, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood. 2008;111:4954–7. https://doi.org/10.1182/blood-2007-11-120667.

    Article  PubMed  CAS  Google Scholar 

  9. Roques G, et al. Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations. Pediatr Blood Cancer. 2014;61:1041–8. https://doi.org/10.1002/pbc.24964.

    Article  PubMed  CAS  Google Scholar 

  10. Pannicke U, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet. 2009;41:101–5. https://doi.org/10.1038/ng.265.

    Article  PubMed  CAS  Google Scholar 

  11. Lagresle-Peyrou C, et al. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet. 2009;41:106–11. https://doi.org/10.1038/ng.278.

    Article  PubMed  CAS  Google Scholar 

  12. Six E, et al. AK2 deficiency compromises the mitochondrial energy metabolism required for differentiation of human neutrophil and lymphoid lineages. Cell Death Dis. 2015;6:e1856. https://doi.org/10.1038/cddis.2015.211.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Al-Zahrani D, Al-Ghonaium A, Al-Mousa H, Al-Kassar A, Roifman CM. Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis. J Allergy Clin Immunol. 2013;132:993–6. https://doi.org/10.1016/j.jaci.2013.04.055.

    Article  PubMed  Google Scholar 

  14. Boztug K, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med. 2009;360:32–43. https://doi.org/10.1056/NEJMoa0805051.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Banka S. GeneReviews is a registered trademark of the University of Washington, Seattle. In: Pagon, RA, et al., editors. GeneReviews(R). University of Washington, Seattle, University of Washington, Seattle. All rights reserved; 1993.

    Google Scholar 

  16. Jun HS, et al. Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome. Blood. 2010;116:2783–92. https://doi.org/10.1182/blood-2009-12-258491.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Jun HS, Cheung YY, Lee YM, Mansfield BC, Chou JY. Glucose-6-phosphatase-beta, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality. Blood. 2012;119:4047–55. https://doi.org/10.1182/blood-2011-09-377820.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Horwitz MS, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007;109:1817–24. https://doi.org/10.1182/blood-2006-08-019166.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Dale DC, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96:2317–22.

    PubMed  CAS  Google Scholar 

  20. Horwitz MS, Corey SJ, Grimes HL, Tidwell T. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol Oncol Clin North Am. 2013;27:19–41., vii. https://doi.org/10.1016/j.hoc.2012.10.004.

    Article  PubMed  Google Scholar 

  21. Person RE, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003;34:308–12. https://doi.org/10.1038/ng1170.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Zarebski A, et al. Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1. Immunity. 2008;28:370–80. https://doi.org/10.1016/j.immuni.2007.12.020.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Devriendt K, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001;27:313–7. https://doi.org/10.1038/85886.

    Article  PubMed  CAS  Google Scholar 

  24. Ancliff PJ, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood. 2006;108:2182–9. https://doi.org/10.1182/blood-2006-01-010249.

    Article  PubMed  CAS  Google Scholar 

  25. Makaryan V, et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol. 2015;22:3–11. https://doi.org/10.1097/moh.0000000000000105.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Palmer SE, Stephens K, Dale DC. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. Am J Med Genet. 1996;66:413–22. https://doi.org/10.1002/(sici)1096-8628(19961230)66:4<413::aid-ajmg5>3.0.co;2-l.

    Article  PubMed  CAS  Google Scholar 

  27. Wright DG, Dale DC, Fauci AS, Wolff SM. Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore). 1981;60:1–13.

    Article  CAS  Google Scholar 

  28. Dale DC, Hammond WPT. Cyclic neutropenia: a clinical review. Blood Rev. 1988;2:178–85.

    Article  CAS  PubMed  Google Scholar 

  29. Souid AK. Congenital cyclic neutropenia. Clin Pediatr. 1995;34:151–5.

    Article  CAS  Google Scholar 

  30. Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist. 2004;9:247–58.

    Article  PubMed  Google Scholar 

  31. Loughran TP Jr, Clark EA, Price TH, Hammond WP. Adult-onset cyclic neutropenia is associated with increased large granular lymphocytes. Blood. 1986;68:1082–7.

    PubMed  Google Scholar 

  32. Hernandez PA, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet. 2003;34:70–4. https://doi.org/10.1038/ng1149.

    Article  PubMed  CAS  Google Scholar 

  33. Balabanian K, et al. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood. 2005;105:2449–57. https://doi.org/10.1182/blood-2004-06-2289.

    Article  PubMed  CAS  Google Scholar 

  34. Balabanian K, et al. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J Clin Invest. 2008;118:1074–84. https://doi.org/10.1172/jci33187.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Al Ustwani O, Kurzrock R, Wetzler M. Genetics on a WHIM. Br J Haematol. 2014;164:15–23. https://doi.org/10.1111/bjh.12574.

    Article  CAS  PubMed  Google Scholar 

  36. McDermott DH, et al. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood. 2014;123:2308–16. https://doi.org/10.1182/blood-2013-09-527226.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Dale DC, et al. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis WHIM syndrome. Blood. 2011;118:4963–6. https://doi.org/10.1182/blood-2011-06-360586.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Dale DC. Immune and idiopathic neutropenia. Curr Opin Hematol. 1998;5:33–6.

    Article  CAS  PubMed  Google Scholar 

  39. Huizinga TW, et al. Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood. 1990;76:1927–32.

    PubMed  CAS  Google Scholar 

  40. Stroncek DF, et al. Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fc-gamma receptor III with maternal deficiency of CD16 antigen. Blood. 1991;77:1572–80.

    PubMed  CAS  Google Scholar 

  41. Fromont P, et al. Frequency of the polymorphonuclear neutrophil Fc gamma receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia. Blood. 1992;79:2131–4.

    PubMed  CAS  Google Scholar 

  42. Maheshwari A, Christensen RD, Calhoun DA. Immune-mediated neutropenia in the neonate. Acta Paediatr Suppl. 2002;91:98–103.

    Article  CAS  PubMed  Google Scholar 

  43. Akhtari M, Curtis B, Waller EK. Autoimmune neutropenia in adults. Autoimmun Rev. 2009;9:62–6. https://doi.org/10.1016/j.autrev.2009.03.006.

    Article  PubMed  CAS  Google Scholar 

  44. Farruggia P. Immune neutropenias of infancy and childhood. World J Pediatr: WJP. 2016;12:142–8. https://doi.org/10.1007/s12519-015-0056-9.

    Article  PubMed  CAS  Google Scholar 

  45. Barbosa MD, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature. 1996;382:262–5. https://doi.org/10.1038/382262a0.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Nagle DL, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet. 1996;14:307–11. https://doi.org/10.1038/ng1196-307.

    Article  PubMed  CAS  Google Scholar 

  47. Eapen M, et al. Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant. 2007;39:411–5. https://doi.org/10.1038/sj.bmt.1705600.

    Article  PubMed  CAS  Google Scholar 

  48. Gallin JI, et al. Human neutrophil-specific granule deficiency: a model to assess the role of neutrophil-specific granules in the evolution of the inflammatory response. Blood. 1982;59:1317–29.

    PubMed  CAS  Google Scholar 

  49. Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon. J Exp Med. 1999;189:1847–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem. 1998;273:28545–8.

    Article  CAS  PubMed  Google Scholar 

  51. Gombart AF, Koeffler HP. Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBP(epsilon). Curr Opin Hematol. 2002;9:36–42.

    Article  PubMed  Google Scholar 

  52. Wynn RF, et al. Intractable diarrhoea of infancy caused by neutrophil specific granule deficiency and cured by stem cell transplantation. Gut. 2006;55:292–3. https://doi.org/10.1136/gut.2005.081927.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170–200.

    Article  CAS  Google Scholar 

  54. Reeves EP, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002;416:291–7. https://doi.org/10.1038/416291a.

    Article  PubMed  CAS  Google Scholar 

  55. Winkelstein JA, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.

    Article  CAS  Google Scholar 

  56. Lublin M, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235:383–91.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Leiding JW, et al. Corticosteroid therapy for liver abscess in chronic granulomatous disease. Clin Infect Dis. 2012;54:694–700. https://doi.org/10.1093/cid/cir896.

    Article  PubMed  CAS  Google Scholar 

  58. Marciano BE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–8.

    Article  PubMed  Google Scholar 

  59. Uzel G, et al. Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429–34. https://doi.org/10.1086/657308.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Walther MM, et al. The urological manifestations of chronic granulomatous disease. J Urol. 1992;147:1314–8.

    Article  CAS  PubMed  Google Scholar 

  61. Chin TW, Stiehm ER, Falloon J, Gallin JI. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr. 1987;111:349–52.

    Article  CAS  PubMed  Google Scholar 

  62. Quie PG, Belani KK. Corticosteroids for chronic granulomatous disease. J Pediatr. 1987;111:393–4.

    Article  CAS  PubMed  Google Scholar 

  63. Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134:780–3.

    Article  CAS  PubMed  Google Scholar 

  64. Kim SJ, Kim JG, Yu YS. Chorioretinal lesions in patients with chronic granulomatous disease. Retina (Philadelphia, Pa). 2003;23:360–5.

    Article  Google Scholar 

  65. Manzi S, et al. Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. Arthritis Rheum. 1991;34:101–5.

    Article  CAS  PubMed  Google Scholar 

  66. Cale CM, Morton L, Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol. 2007;148:79–84. https://doi.org/10.1111/j.1365-2249.2007.03321.x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Vowells SJ, et al. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr. 1996;128:104–7.

    Article  CAS  PubMed  Google Scholar 

  68. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89–97.

    Article  CAS  PubMed  Google Scholar 

  69. Nauseef WM. Myeloperoxidase deficiency. Hematol Oncol Clin North Am. 1988;2:135–58.

    Article  CAS  PubMed  Google Scholar 

  70. Okuda T, Yasuoka T, Oka N. Myeloperoxidase deficiency as a predisposing factor for deep mucocutaneous candidiasis: a case report. J Oral Maxillofac Surg (Official Journal of the American Association of Oral and Maxillofacial Surgeons). 1991;49:183–6.

    Article  CAS  Google Scholar 

  71. Ludviksson BR, Thorarensen O, Gudnason T, Halldorsson S. Candida albicans meningitis in a child with myeloperoxidase deficiency. Pediatr Infect Dis J. 1993;12:162–4.

    Article  CAS  PubMed  Google Scholar 

  72. Nguyen C, Katner HP. Myeloperoxidase deficiency manifesting as pustular candidal dermatitis. Clin Infect Dis. 1997;24:258–60.

    Article  CAS  PubMed  Google Scholar 

  73. Chiang AK, et al. Disseminated fungal infection associated with myeloperoxidase deficiency in a premature neonate. Pediatr Infect Dis J. 2000;19:1027–9.

    Article  CAS  PubMed  Google Scholar 

  74. Notarangelo LD, Badolato R. Leukocyte trafficking in primary immunodeficiencies. J Leukoc Biol. 2009;85:335–43. https://doi.org/10.1189/jlb.0808474.

    Article  PubMed  CAS  Google Scholar 

  75. Anderson DC, et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis. 1985;152:668–89.

    Article  CAS  PubMed  Google Scholar 

  76. Kuijpers TW, et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest. 1997;100:1725–33. https://doi.org/10.1172/jci119697.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Hogg N, et al. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest. 1999;103:97–106. https://doi.org/10.1172/jci3312.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Thomas C, et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood. 1995;86:1629–35.

    PubMed  CAS  Google Scholar 

  79. Qasim W, et al. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics. 2009;123:836–40. https://doi.org/10.1542/peds.2008-1191.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Uzel G, et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood. 2008;111:209–18. https://doi.org/10.1182/blood-2007-04-082552.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  81. Lubke T, et al. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73–6. https://doi.org/10.1038/88299.

    Article  PubMed  CAS  Google Scholar 

  82. Luhn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69–72. https://doi.org/10.1038/88289.

    Article  PubMed  CAS  Google Scholar 

  83. Gazit Y, et al. Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol. 2010;30:308–13. https://doi.org/10.1007/s10875-009-9354-0.

    Article  PubMed  CAS  Google Scholar 

  84. Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol. 1998;102:323–4.

    Article  CAS  PubMed  Google Scholar 

  85. Marquardt T, et al. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999;94:3976–85.

    PubMed  CAS  Google Scholar 

  86. Etzioni A, Tonetti M. Fucose supplementation in leukocyte adhesion deficiency type II. Blood. 2000;95:3641–3.

    PubMed  CAS  Google Scholar 

  87. Mory A, et al. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood. 2008;112:2591. https://doi.org/10.1182/blood-2008-06-163162.

    Article  PubMed  CAS  Google Scholar 

  88. Kuijpers TW, et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood. 2009;113:4740–6. https://doi.org/10.1182/blood-2008-10-182154.

    Article  PubMed  CAS  Google Scholar 

  89. Stepensky PY, et al. Leukocyte adhesion deficiency type III: clinical features and treatment with stem cell transplantation. J Pediatr Hematol Oncol. 2015;37:264–8. https://doi.org/10.1097/mph.0000000000000228.

    Article  PubMed  CAS  Google Scholar 

  90. Ambruso DR, et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A. 2000;97:4654–9. https://doi.org/10.1073/pnas.080074897.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Williams DA, et al. Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood. 2000;96:1646–54.

    PubMed  CAS  Google Scholar 

  92. Routes JM, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009;302:2465–70. https://doi.org/10.1001/jama.2009.1806.

    Article  PubMed  CAS  Google Scholar 

  93. Accetta D, et al. Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol. 2011;127:535–538.e531-532. https://doi.org/10.1016/j.jaci.2010.10.013.

    Article  PubMed  CAS  Google Scholar 

  94. Alkhairy OK, et al. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J Allergy Clin Immunol. 2015;135:1380–1384.e1381-1385. https://doi.org/10.1016/j.jaci.2014.10.039.

    Article  PubMed  CAS  Google Scholar 

  95. Grimbacher B, et al. Hyper-IgE syndrome with recurrent infections – an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692–702. https://doi.org/10.1056/nejm199903043400904.

    Article  PubMed  CAS  Google Scholar 

  96. Minegishi Y, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62. https://doi.org/10.1038/nature06096.

    Article  PubMed  CAS  Google Scholar 

  97. Holland SM, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–19. https://doi.org/10.1056/NEJMoa073687.

    Article  PubMed  CAS  Google Scholar 

  98. Minegishi Y, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med. 2009;206:1291–301. https://doi.org/10.1084/jem.20082767.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Freeman AF, et al. Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol. 2013;33:896–902. https://doi.org/10.1007/s10875-013-9890-5.

    Article  PubMed  CAS  Google Scholar 

  100. Freeman AF, Holland SM. The hyper-IgE syndromes. Immunol Allergy Clin N Am. 2008;28:277–91., viii. https://doi.org/10.1016/j.iac.2008.01.005.

    Article  Google Scholar 

  101. Ling JC, et al. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol (Orlando, Fla). 2007;122:255–8. https://doi.org/10.1016/j.clim.2006.10.005.

    Article  CAS  Google Scholar 

  102. Freeman AF, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics. 2007;119:e1121–5. https://doi.org/10.1542/peds.2006-2649.

    Article  PubMed  Google Scholar 

  103. Engelhardt KR, et al. The extended clinical phenotype of 64 patients with DOCK8 deficiency. J Allergy Clin Immunol. 2015;136:402–12. https://doi.org/10.1016/j.jaci.2014.12.1945.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  104. Zhang Q, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046–55. https://doi.org/10.1056/NEJMoa0905506.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  105. Engelhardt KR, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289–1302.e1284. https://doi.org/10.1016/j.jaci.2009.10.038.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  106. Sassi A, et al. Hypomorphic, homozygous mutations in phosphoglucomutase 3 impair immunity and increase serum IgE levels. J Allergy Clin Immunol. 2014;133:1410–142013. https://doi.org/10.1016/j.jaci.2014.02.025.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Zhang Y, et al. Autosomal recessive PGM3 mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol. 2014;133:1400–1409.e1405. https://doi.org/10.1016/j.jaci.2014.02.013.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  108. Minegishi Y, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25:745–55. https://doi.org/10.1016/j.immuni.2006.09.009.

    Article  PubMed  CAS  Google Scholar 

  109. Kreins AY, et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. 2015;212:1641–62. https://doi.org/10.1084/jem.20140280.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  110. Bogunovic D, et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science. 2012;337:1684–8. https://doi.org/10.1126/science.1224026.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  111. Hambleton S, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med. 2011;365:127–38. https://doi.org/10.1056/NEJMoa1100066.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  112. Haverkamp MH, van Dissel JT, Holland SM. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Microbes Infect. 2006;8:1157–66. https://doi.org/10.1016/j.micinf.2005.10.029.

    Article  PubMed  CAS  Google Scholar 

  113. Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–51.; quiz 1052–1043. https://doi.org/10.1016/j.jaci.2008.10.037.

    Article  PubMed  CAS  Google Scholar 

  114. de Vor IC, et al. Deletion of the entire interferon-gamma receptor 1 gene causing complete deficiency in three related patients. J Clin Immunol. 2016;36:195–203. https://doi.org/10.1007/s10875-016-0244-y.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  115. Prando C, et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore). 2013;92:109–22. https://doi.org/10.1097/MD.0b013e31828a01f9.

    Article  CAS  Google Scholar 

  116. Martinez-Barricarte R, et al. Mycobacterium simiae infection in two unrelated patients with different forms of inherited IFN-gammaR2 deficiency. J Clin Immunol. 2014;34:904–9. https://doi.org/10.1007/s10875-014-0085-5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  117. Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15:968–80. https://doi.org/10.1016/s1473-3099(15)00089-4.

    Article  PubMed  CAS  Google Scholar 

  118. Spinner MA, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809–21. https://doi.org/10.1182/blood-2013-07-515528.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  119. Grabbe C, Husnjak K, Dikic I. The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol. 2011;12:295–307. https://doi.org/10.1038/nrm3099.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  120. Smahi A, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. Int Incontinentia Pigmenti (IP) Consortium Nat. 2000;405:466–72.

    CAS  Google Scholar 

  121. Filipe-Santos O, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203:1745–59. https://doi.org/10.1084/jem.20060085.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  122. Orange JS, et al. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol. 2004;113:725–33. https://doi.org/10.1016/j.jaci.2004.01.762.

    Article  PubMed  CAS  Google Scholar 

  123. Ferwerda B, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med. 2009;361:1760–7. https://doi.org/10.1056/NEJMoa0901053.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  124. Glocker EO, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009;361:1727–35. https://doi.org/10.1056/NEJMoa0810719.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  125. Toubiana J, Okada S, Hiller J, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA

    Jana P. Lovell & Steven M. Holland

Authors
  1. Jana P. Lovell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven M. Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven M. Holland .

Editor information

Editors and Affiliations

  1. Departments of Medicine and Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA

    Brahm H. Segal

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lovell, J.P., Holland, S.M. (2018). Defects of Innate Immunity. In: Segal, B. (eds) Management of Infections in the Immunocompromised Host. Springer, Cham. https://doi.org/10.1007/978-3-319-77674-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-77674-3_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-77672-9

  • Online ISBN: 978-3-319-77674-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation